Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03127215 |
Title | Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT-PMO-1603) |
Acronym | NCT-PMO-1603 |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | National Center for Tumor Diseases, Heidelberg |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | DEU |